IndraLab

Statements

P5091 inhibits tumor growth. 1 / 1

| 1

eidos

"In addition , P5091 inhibits tumor growth and synergizes with other chemotherapeutic agents such as lenalidomide , HDAC inhibitor or dexamethasone to induce synergistic anti-multiple myeloma effect [ 32 , 33 ] ."

32002017

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

P5091 inhibits tumor growth. 1 / 1

INDRA sources:

Databases

Reading